🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchEfinopegdutide — MASH-focused GCG/GLP-1 from Merck/Hanmi Page 2

Efinopegdutide — MASH-focused GCG/GLP-1 from Merck/Hanmi

MASHdoc_SA Mon, Feb 23, 2026 at 7:54 AM 8 replies 347 viewsPage 2 of 2
Dr.CardioMD
VIP Member
2,678
14,567
Dec 2023
Cleveland, OH
Feb 23, 2026 at 10:44 AM#6
JennaRN said:
Short answer: talk to your prescriber first

Gonna push back on this one. Efinopegdutide MASH-focused is not that straightforward in my experience. I have been on this for 18 months and the reality is messier than the trials suggest.

Don't get me wrong — the medication works. But adherence is harder than people admit. We should be honest about that.

6 24kim_atl_prep, sarah_TO, wendy_avl and 3 others
Reply Quote Save Share Report
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Feb 23, 2026 at 11:01 AM#7

Adding my data to this Efinopegdutide discussion:

MetricBaselineMonth 3Month 8
Weight262 lbs247 lbs207 lbs
A1C6.6%5.8%5.4%
hsCRP6.02.01.2

Protocol: Semaglutide 2.4mg/wk, resistance training 3x/wk, protein 1.4g/kg/day.

12 4JenPlateau, SallyK_inj, CryptoCarl and 9 others
Reply Quote Save Share Report
MariaRD
Member
823
4,567
Jun 2024
New Mexico
Feb 23, 2026 at 11:18 AM#8

Dr.EndoIndy — wow. I've been looking for this exact info for weeks.

7 18maria_elpaso, anders_CPH, Dr.NutriCornell and 4 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
greg_boulder
Member
345
1,567
Jul 2024
Boulder, CO
Feb 23, 2026 at 11:35 AM#9

Slightly tangential to Efinopegdutide but SleepDoc_PDX reminded me — has anyone else noticed changes in their alcohol tolerance?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

41 23patPC_UT, Dr.DermMIA, fiona_VT and 38 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Feb 23, 2026 at 11:52 AM#10

Moderator note: This thread has been getting great engagement. Please remember to cite sources when making clinical claims.

No issues to report — carry on. 👍

34 13PurityPaulOR, MaxMetOK, MounjBrad and 31 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register